PMC:7784786 / 11812-11975 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"412","span":{"begin":4,"end":12},"obj":"Species"},{"id":"414","span":{"begin":151,"end":161},"obj":"Chemical"},{"id":"415","span":{"begin":31,"end":39},"obj":"Disease"},{"id":"416","span":{"begin":54,"end":68},"obj":"Disease"}],"attributes":[{"id":"A412","pred":"tao:has_database_id","subj":"412","obj":"Tax:9606"},{"id":"A414","pred":"tao:has_database_id","subj":"414","obj":"MESH:C000597346"},{"id":"A415","pred":"tao:has_database_id","subj":"415","obj":"MESH:C000657245"},{"id":"A416","pred":"tao:has_database_id","subj":"416","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ree patients with diagnosis of COVID-19 classified as critically ill (two) and severely ill (one) were included in an expanded access trial to receive itolizumab i"}